2,384 Followers on Owler

bluebird bio

is a Massachusetts-based biotechnology company that researches and develops gene therapies for the treatment of genetic diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

bluebird bio

is a Massachusetts-based biotechnology company that researches and develops gene therapies for the treatment of genetic diseases... Read more
bluebird bio CEO: Andrew Obenshain

CEO

Andrew Obenshain

CEO Approval Rating

73/100

1992

PublicAcquired by The Carlyle GroupNASDAQBLUE

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$103.9M
Employees
520
Funding
$821.4M
Acquisitions
1

News

Acquisition
Feb 21, 2025
Business Wire
bluebird bio Was acquired by The Carlyle Group for undisclosed amounted

bluebird bio Competitors

1Sangamo
2Intellia Therapeutics
3CRISPR
4Emmaus
5Elcelyx Therapeutics
6Gelesis
7Asklepios
8Dimension Therapeutics
9Lysogene
10Merck
Unlock 12 + competitors

Trending Companies